These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12878548)

  • 1. In vivo efficacy of the ketolide ABT-773 (cethromycin) against enterococci in a mouse peritonitis model.
    Pai SR; Singh KV; Murray BE
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2706-9. PubMed ID: 12878548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of telithromycin (HMR 3647) against enterococci in a mouse peritonitis model.
    Singh KV; Zscheck KK; Murray BE
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3434-7. PubMed ID: 11083653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Tedizolid against Enterococci and Staphylococci, Including
    Singh KV; Arias CA; Murray BE
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.
    Kim MK; Zhou W; Tessier PR; Xuan D; Ye M; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3185-92. PubMed ID: 12234843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci.
    Singh KV; Malathum K; Murray BE
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3640-3. PubMed ID: 11709359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria.
    Malathum K; Coque TM; Singh KV; Murray BE
    Antimicrob Agents Chemother; 1999 Apr; 43(4):930-6. PubMed ID: 10103202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antimicrobial activity of ABT-773, a novel ketolide, tested against drug-resistant Gram-positive cocci and Haemophilus influenzae.
    Rospide MF; Biedenbach DJ; Jones RN
    Int J Antimicrob Agents; 2001 Jun; 17(6):451-5. PubMed ID: 11397614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of ketolide ABT-773 (cethromycin) against erythromycin-resistant Streptococcus pneumoniae: correlation with extended MLSK phenotypes.
    Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 2002 Dec; 50(6):907-13. PubMed ID: 12461012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of ceftobiprole medocaril against Enterococcus faecalis in a mouse peritonitis model.
    Arias CA; Singh KV; Panesso D; Murray BE
    J Antimicrob Chemother; 2007 Sep; 60(3):594-8. PubMed ID: 17606481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
    Hammerschlag MR; Reznik T; Roblin PM; Ramirez J; Summersgill J; Bukofzer S
    J Antimicrob Chemother; 2003 Apr; 51(4):1025-8. PubMed ID: 12654764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype.
    Song JH; Ko KS; Suh JY; Oh WS; Kang CI; Chung DR; Peck KR; Lee NY; Lee WG
    J Antimicrob Chemother; 2008 Apr; 61(4):838-44. PubMed ID: 18230690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ketolides and oxazolidinones. Mechanisms of action and antibacterial spectrum].
    Muller-Serieys C
    Presse Med; 2000 Dec; 29(37):2061-4. PubMed ID: 11155736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipneumococcal activity of ABT-773 compared to those of 10 other agents.
    Davies TA; Ednie LM; Hoellman DM; Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1894-9. PubMed ID: 10858350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.
    Cynamon MH; Carter JL; Shoen CM
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2895-6. PubMed ID: 10991883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-773: a new ketolide antibiotic.
    Dougherty TJ; Barrett JF
    Expert Opin Investig Drugs; 2001 Feb; 10(2):343-51. PubMed ID: 11178346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of a novel ketolide ABT-773 against invasive strains of Streptococcus pneumoniae.
    Weiss K; de Azavedo J; Restieri C; Quach C; Laverdiere M; Rubin E; Gourdeau M; Low DE
    J Antimicrob Chemother; 2001 Sep; 48(3):407-9. PubMed ID: 11533007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model.
    Azoulay-Dupuis E; Mohler J; Bédos JP; Barau C; Fantin B
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3033-8. PubMed ID: 16940099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimum inhibitory concentration versus minimum biofilm eliminating concentration in evaluation of antibiotic sensitivity of enterococci causing peritonitis.
    Sepandj F; Ceri H; Gibb A; Read R; Olson M
    Perit Dial Int; 2007; 27(4):464-5. PubMed ID: 17602158
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of daptomycin efficacy and breakpoint standards in a murine model of Enterococcus faecalis and Enterococcus faecium renal infection.
    Alder J; Li T; Yu D; Morton L; Silverman J; Zhang XX; Critchley I; Thorne G
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3561-6. PubMed ID: 14576118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of the ketolide ABT-773.
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2922-4. PubMed ID: 11557491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.